Neuberger Berman Group LLC Grows Stock Position in STERIS plc $STE

Neuberger Berman Group LLC boosted its holdings in shares of STERIS plc (NYSE:STE) by 64.7% in the second quarter, HoldingsChannel.com reports. The fund owned 19,416 shares of the medical equipment provider’s stock after buying an additional 7,630 shares during the quarter. Neuberger Berman Group LLC’s holdings in STERIS were worth $4,664,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Mediolanum International Funds Ltd increased its position in STERIS by 9.0% during the second quarter. Mediolanum International Funds Ltd now owns 62,327 shares of the medical equipment provider’s stock worth $14,883,000 after buying an additional 5,156 shares in the last quarter. Entropy Technologies LP raised its stake in STERIS by 282.2% in the 2nd quarter. Entropy Technologies LP now owns 9,099 shares of the medical equipment provider’s stock valued at $2,186,000 after purchasing an additional 6,718 shares during the last quarter. Vanguard Group Inc. lifted its position in STERIS by 1.7% during the second quarter. Vanguard Group Inc. now owns 12,163,128 shares of the medical equipment provider’s stock worth $2,921,827,000 after buying an additional 205,276 shares during the period. KLP Kapitalforvaltning AS boosted its stake in STERIS by 5.3% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 33,800 shares of the medical equipment provider’s stock worth $8,119,000 after buying an additional 1,700 shares during the last quarter. Finally, Foresight Group Ltd Liability Partnership acquired a new position in shares of STERIS during the 1st quarter valued at about $25,958,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently commented on STE. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 14th. Morgan Stanley lifted their target price on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research report on Friday, August 8th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus target price of $273.50.

STERIS Stock Down 0.2%

NYSE:STE opened at $266.28 on Friday. The stock has a 50-day simple moving average of $248.65 and a 200 day simple moving average of $242.79. STERIS plc has a one year low of $200.98 and a one year high of $268.60. The company has a market capitalization of $26.13 billion, a price-to-earnings ratio of 40.78 and a beta of 1.02. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.53 and a current ratio of 2.22.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, topping the consensus estimate of $2.38 by $0.09. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the firm earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Sell-side analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Tuesday, November 18th will be paid a dividend of $0.63 per share. The ex-dividend date is Tuesday, November 18th. This represents a $2.52 annualized dividend and a yield of 0.9%. STERIS’s dividend payout ratio is 36.21%.

Insider Buying and Selling

In other news, VP Renato Tamaro sold 5,036 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the transaction, the vice president directly owned 5,695 shares of the company’s stock, valued at approximately $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $262.00, for a total value of $1,312,096.00. Following the completion of the sale, the vice president directly owned 10,710 shares in the company, valued at approximately $2,806,020. This trade represents a 31.86% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 25,203 shares of company stock valued at $6,624,667. 1.07% of the stock is currently owned by insiders.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.